MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.intimp.2025.116062

Медицинская библиотека · International immunopharmacology · 2025

Propranolol metabolite and enantiomers affect colorectal cancer development by inhibiting MAPK pathway and downregulating PD-1 expression.

Yi Hanying, Dai Yingying, Chen Cuiyu, Ma Wenjuan, Zhang Yu, Wang Shiyu, Jing Ouyang, Liu Dongbo, Wan Jielin, Wang Yang, Liu Jie, Mcleod Howard L, Chen Lin, He Yijing

СтатьяПеревод в очереди

Аннотация

Preclinical and clinical studies have demonstrated the tumor-suppressive role of propranolol, a racemic mixture that blocks β2-adrenergic receptor (β2-AR). However, the impact of 4-hydroxypropranolol, the primary metabolite of propranolol, as well as the two enantiomers of propranolol, in tumor control remains uncertain. In this study, we investigated the effects of propranolol, 4-hydroxypropranolol, and propranolol enantiomers in controlling colorectal cancer. These compounds demonstrated time- and concentration-dependent inhibition of cancer cell viability in vitro and significantly suppressed tumor growth in vivo. Notably, 4-hydroxypropranolol exhibited the most potent tumor suppressive effect among all tested compounds. Computational analyses revealed that 4-hydroxypropranolol exhibited stronger binding to β2-AR compared with propranolol (hydrogen-bond distance: 2.8 Å vs 3.1 Å). Additionally, 4-hydroxypropranolol markedly reduced the population of PD-1+CD4+T cells and PD-1+CD8+T cells in the spleen of colorectal cancer models. Furthermore, treatment with 4-hydroxypropranolol (8 mg/kg/day) significantly diminished the population of FoxP3+CD4+CD25+ T (Treg) cells in the spleens of animals, compared to the PBS group. These findings suggest that 4-hydroxypropranolol exerts a stronger tumor suppressor effect than propranolol and its enantiomers, likely due to its higher affinity for β2-AR.

Для цитирования: Yi Hanying, Dai Yingying, Chen Cuiyu, Ma Wenjuan, Zhang Yu, Wang Shiyu, Jing Ouyang, Liu Dongbo, Wan Jielin, Wang Yang, Liu Jie, Mcleod Howard L, Chen Lin, He Yijing. Propranolol metabolite and enantiomers affect colorectal cancer development by inhibiting MAPK pathway and downregulating PD-1 expression.. International immunopharmacology. 2025. DOI: 10.1016/j.intimp.2025.116062.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.